Ticker ONCOZListed on Nasdaq Stockholm
OncoZenge AB
At a glance
Most recent filing on August 28, 2026 — an open-market purchase by Paul Murtagh on Aug 28, 2026.
We hold 16 visible filings, going back to March 5, 2021.
Filings we could not classify with confidence are set aside for review, so they are in none of these counts.
Insider trades
What is a MAR filing?5 of 16 shown
- Paul Murtagh Board member101,000 SEKOpen-market buy
- Paul Murtagh Board member95,400 SEKOpen-market buy
- Stian Kildal Chief executive officer397,495 SEKOpen-market buy
- Stian Kildal Chief executive officer157,500 SEKOpen-market buy
- Stian Kildal Chief executive officer173,507 SEKOpen-market buy